Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Director/PDMR Shareholding

11 Jun 2012 08:30

RNS Number : 0480F
Imaginatik PLC
11 June 2012
 

 

 

11 June 2012

Imaginatik Plc

 

("Imaginatik" or "the Company")

 

Directors' Dealings

 

The Company announced earlier today that it was proposing to raise up to £1million before expenses through a conditional placing of up to 333,333,333 new ordinary shares (the "Placing Shares") with institutional and other investors at a price of 0.3p per Placing Share (the "Placing") and that it had received irrevocable commitments to subscribe for 285,833,333 Placing Shares and expressions of interest from certain Directors of the Company to subscribe for a further 47,500,000 Placing Shares in the Placing on the same terms.

 

Following the release of its audited results for the year ended 31 March 2012, the Company is pleased to announce that Messrs Cooper, Charles and Gammon, Directors of the Company, have conditionally subscribed in the Placing for in aggregate 47,500,000 Placing Shares, as set out below, at a price of 0.3p per Placing Share.

 

In aggregate, the Company has therefore conditionally raised £1 million before expenses through a conditional placing of 333,333,333 new ordinary shares at a price of 0.3p per Placing Share.

 

The 333,333,333 new ordinary shares to be issued pursuant to the Placing will be credited as fully paid and will rank pari passu in all respects with the existing ordinary shares, including the right to receive all dividends and other distributions declared on or after the date on which they are issued.

 

Application will be made for admission of the 333,333,333 new ordinary shares to trading on AIM ("Admission") and, subject to the requisite shareholder approval for the Placing being obtained at the General Meeting to be held on 27 June 2012, it is expected that Admission will be effective on or around 8.00 am on 28 June 2012.

 

Directors' participation in the Placing

The following directors of the Company are participating in the Placing at the Placing Price:

 

Director

Number of Placing Shares conditionally subscribed for

Amount subscribed

£

Number of shares held including Placing Shares

Percentage of enlarged issued share capital at Admission

Options held

Simon Charles

7,500,000

22,500

19,511,771

2.31

2,000,000

Matt Cooper

 25,000,000

75,000

80,139,615

9.47

19,062,500

David Gammon

 15,000,000*

45,000

27,442,564**

3.24

2,000,000

 

*includes a subscription for 8,333,333 Placing Shares for the sum of £25,000 by Sarah Gammon, the wife of David Gammon.

 

** The interest of David Gammon includes those of his wife.

 

 

The issue of the 47,500,000 Placing Shares to Directors of the Company is deemed a related party transaction under the AIM Rules for Companies. Shawn Taylor, Luis Solis, Brian Hays and Nick Goss, the independent directors, consider, having consulted with Northland Capital Partners Limited as the Company's Nominated Adviser, that the terms of the Directors' participation in the Placing are fair and reasonable insofar as shareholders of the Company are concerned.

 

Issue of options

 

Subject to Admission, Northland Capital Partners Limited has been issued 5,895,833 options to subscribe for new ordinary shares in the Company at a price of 0.5p per new ordinary share for a period of five years from the date of the General Meeting.

 

Total voting rights

 

Following the Admission of the 333,333,333 new ordinary shares to be issued pursuant to the the Placing, the Company's total issued share capital will comprise of 846,365,443 ordinary shares. The Company does not hold any ordinary shares in treasury. Therefore the total number of shares with voting rights in the Company will be 846,365,443. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company following Admission.

 

 

For further information please contact:

 

Imaginatik plc

Tel: 020 7917 2975

Matt Cooper, Chairman / Shawn Taylor, CFO

Northland Capital Partners Limited

Tel: 020 7796 8800

Gavin Burnell / Edward Hutton

John Howes / Alice Lane (Broking)

 

Newgate Threadneedle

Tel: 020 7653 9850

Caroline Evans-Jones / Hilary Millar

 

About Imaginatik

Imaginatik provides a range of Innovation solutions comprised of consultancy, enterprise software and program management to deliver innovation results to companies such as The World Bank, NYSE, The Chubb Group of Insurance Companies, Boeing, Pfizer, Goodyear, Paccar, Kellogg and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. Imaginatik's mission is to help these companies build sustainable innovation competencies.

 

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and is a World Economic Forum Technology Pioneer with offices in Boston, MA, and Winchester, UK. For more information visit www.imaginatik.com.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFMMPTMBABBLT
Date   Source Headline
27th Nov 20137:00 amRNSHalf Yearly Report
24th Oct 20137:00 amRNSContract Win
10th Oct 201310:01 amRNSHolding(s) in Company
2nd Oct 20137:00 amRNSIssue of Equity
1st Oct 201310:03 amRNSTransaction in Own Shares/Director's Dealing
23rd Sep 20137:00 amRNSContract Win with Shell
18th Sep 20132:03 pmRNSResult of AGM
27th Aug 20131:50 pmRNSNotice of AGM
24th Jul 20137:00 amRNSFinal Results
8th Jul 20137:00 amRNSContract Win
1st Jul 20137:00 amRNSChange of Adviser
21st Jun 20137:00 amRNSBoard Changes
13th Jun 20137:00 amRNSConsultancy Update
31st May 20137:00 amRNSTotal Voting Rights
16th May 20131:03 pmRNSHolding(s) in Company
16th May 20137:00 amRNSHolding(s) in Company
13th May 201312:16 pmRNSResult of General Meeting
26th Apr 20134:52 pmRNSPublication of Circular
26th Apr 20137:00 amRNSProposed Placing
16th Apr 201312:20 pmRNSCapital Market Strategy Update
7th Feb 20132:25 pmRNSTrading Update
10th Dec 20127:00 amRNSContract Wins
22nd Nov 20127:00 amRNSShare Options
21st Nov 20127:00 amRNSHalf Yearly Report
25th Oct 20127:00 amRNSTrading Update
2nd Oct 20127:00 amRNSLitigation Conclusion
14th Sep 20121:02 pmRNSResult of AGM
14th Sep 20127:00 amRNSAGM Statement
23rd Aug 20127:00 amRNSNotice of AGM
4th Jul 201212:04 pmRNSHolding(s) in Company
2nd Jul 20122:22 pmRNSHolding(s) in Company
29th Jun 20123:30 pmRNSHolding(s) in Company
29th Jun 201212:12 pmRNSHolding(s) in Company
28th Jun 20121:36 pmRNSHolding(s) in Company
27th Jun 201211:20 amRNSResult of General Meeting
20th Jun 20121:41 pmRNSDirectorate Change
11th Jun 20128:30 amRNSDirector/PDMR Shareholding
11th Jun 20128:00 amRNSFinal Results
11th Jun 20128:00 amRNSProposed Placing
17th Apr 20127:00 amRNSContract Wins
17th Apr 20127:00 amRNSTrading Update
29th Feb 20127:00 amRNSContract with US Healthcare Services Provider
21st Feb 20121:45 pmRNSHolding(s) in Company
20th Feb 201212:54 pmRNSHolding(s) in Company
15th Feb 201212:16 pmRNSHolding(s) in Company
15th Feb 20127:00 amRNSShare Option Schemes
8th Feb 20127:00 amRNSIssue of Equity
3rd Feb 201211:39 amRNSHolding(s) in Company
2nd Feb 201210:49 amRNSHolding(s) in Company
30th Jan 20127:00 amRNSSenior Management Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.